Latest News

Kirkstall and Agenda 1 are selected as finalists for the 2009 CPhI/ICSE Innovation award – Madrid 13-15 October 2009

Kirkstall Limited, the Sheffield-based developer of in vitro systems for testing the safety and efficacy of compounds are pleased to announce that Kirkstall’s Quasi-VivoTM in vitro compound testing system and Agenda 1’s SOLENTTM solubilizing screen have been jointly selected by the CPhI judges as a finalist for the Innovation Award 2009.

Visit us at stand 8NE11

[Download pdf]


Welcome to Kirkstall Ltd

Inter-connected cell culture systems:

Kirkstall has developed an advanced cell culture system to provide in vivo - like conditions for cell growth.

The system can be configured to culture multiple cell types under controlled nutrient flow. By closely mimicking human metabolism the system provides a more physiologically accurate representation than culture grown in static well plates. Kirkstall’s interconnected cell culture systems provide a Quasi VivoTM environment for cell growth. The system has many applications in biotechnology, pharmaceutical, chemical, cosmetic and research industries.

The modular based system incorporates a dynamic flow of nutrients through multiple cell culture chambers. Each chamber can
culture individual cell types or tissue allowing cell-to-cell signalling between and within each chamber.

The result is a high quality screening system which can generate improved metabolic information for many pharmaceutical applications, speeding up drug development, improving product safety and reducing animal testing - and saving money for our clients.

 

The Kirkstall Quasi VivoTM cell culture system is available in a ‘kit’ format (link) or is accessible on a contract research basis from Kirkstall (link)